Clinical trial
Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
NCT00176501 · Rutgers, The State University of New Jersey, Other · Terminated
Key facts
| NCT number | NCT00176501 |
|---|---|
| Title | Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer |
| Official title | Immunotherapy for Patients With Renal Cell Carcinoma |
| Lead sponsor | Rutgers, The State University of New Jersey, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Biological |
| Interventions | therapeutic allogeneic lymphocytes |
| Enrollment | 3 |
| Start date | Aug 1, 2004 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: